The epidemiology of resistance to ofloxacin and oxacillin among clinical coagulase-negative staphylococcal isolates: Analysis of risk factors and strain types

Clinical Infectious Diseases

Volumn 26, Issue 1, 1998, Pages 72-79

  Pegues, David A ^a   Colby, Christine ^c   Hibberd, Patricia L ^c   Cohen, Louise Glassner ^c   Ausubel, Frederick M ^c   Calderwood, Stephen B ^c   Hooper, David C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; OFLOXACIN; OXACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DISEASE TRANSMISSION; HOSPITAL INFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; STRAIN DIFFERENCE;

EID: 0031914818     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516270     Document Type: Article

References (15)

1. Pfaller MA, Herwaldt LA. Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin Microbiol Rev 1988; 1: 281-99.
2. Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am J Med 1991;91(suppl 3B):86S-9S.
3. Blumberg HM, Rimland D, Carroll DJ, Terry P, Wachsmuth IK. Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. J Infect Dis 1991; 163:1279-85.
4. Calderwood SB, Baker MA, Carroll PA, Michel JL, Arbeit RD, Ausubel FM. Use of cleaved amplified polymorphic sequences to distinguish strains of Staphylococcus epidermidis. J Clin Microbiol 1996;34: 2860-5.
5. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests for bacteria that grow aerobically. 3rd ed. Approved standard. Document M7-A3. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1993.
6. Maslow JN, Slutsky AM, Arbeit RD. The application of pulsed-field gel electrophoresis to molecular epidemiology. In: Persing DH, Smith TF, Tenover FC, White TJ, eds. Diagnostic molecular microbiology: principles and applications. Washington, DC: American Society for Microbiology, 1993:563-72.
7. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-9.
8. Dean AG, Dean JA, Burton JA, Dicker RC. Epi-Info, version 6: a word-processing, database, and statistics program for epidemiology for public health on IBM-compatible microcomputers. Atlanta: Centers for Disease Control and Prevention, 1994.
9. Ng EYW, Trucksis M, Hooper DC. Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome. Antimicrob Agents Chemother 1994;38:1345-55.
10. Trucksis M, Hooper DC, Wolfson JS. Emerging resistance to fluoroquinolones in staphylococci: an alert [editorial]. Ann Intern Med 1991; 114: 424-6.
11. Ng EY, Trucksis M, Hooper DC. Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus. Antimicrob Agents Chemother 1996;40:1881-8.
12. Sreedharan S, Peterson LR, Fisher LM. Ciprofloxacin resistance in coagulase-positive and -negative staphylococci: role of mutations at serine 84 in the DNA gyrase A protein of Staphylococcus aurais and Staphylococcus epidermidis. Antimicrob Agents Chemother 1991;35:2151-4.
13. Sreedharan S, Oram M, Jensen B, Peterson LR, Fisher LM. DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus aureus: close similarity with quinolone resistance mutations in Escherichia coli. J Bacteriol 1990; 172:7260-2.
14. Tanaka M, Zhang YX, Ishida H, Akasaka T, Sato K, Hayakawa I. Mechanisms of 4-quinolone resistance in quinolone-resistant and methicillin-resistant Staphylococcus aureus isolates from Japan and China. J Med Microbiol 1995;42:214-9.
15. Smith KR, Cobbs CG. In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Slaphylococcus aureus and Staphylococcus epidermidis. Eur J Clin Microbiol Infect Dis 1992; 11:55-8.